Astellas Acquires Stem Cell Company Ocata Therapeutics At 90% Premium – What … – Seeking Alpha
Seeking Alpha |
Astellas Acquires Stem Cell Company Ocata Therapeutics At 90% Premium – What …
Seeking Alpha While it is not worthwhile to do an in depth analysis of a stem cell company that will soon no longer operate independently, there are lessons to be learned and questions to be asked related to the acquisition and what it means to the stem cell sector … ImmunoCellular Therapeutics Enters into Sponsored Research Agreement with … |
